Neumora Launches With $500m To Advance Personalized Neuroscience Drugs

Funding Includes $100m Under New Amgen Deal

 
• By Mandy Jackson

Combining biological insights with data science, the start-up emerges from stealth mode after two years of assembling its technology platform and R&D pipeline based on internal and external know-how.

Venture capital; Businessman pressing virtual screen inscription
Neumora raised more than $400m to build the company at scale and develop multiple programs at once • Source: Alamy

More from Financing

More from Business